Captrust Financial Advisors Buys Shares of 285,659 Sotera Health (NASDAQ:SHC)

Captrust Financial Advisors purchased a new position in shares of Sotera Health (NASDAQ:SHC) in the third quarter, HoldingsChannel reports. The fund purchased 285,659 shares of the company’s stock, valued at approximately $4,771,000.

A number of other institutional investors have also modified their holdings of the company. Walleye Capital LLC acquired a new stake in Sotera Health during the third quarter worth approximately $1,410,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Sotera Health by 14.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,301 shares of the company’s stock valued at $456,000 after acquiring an additional 3,380 shares during the last quarter. MetLife Investment Management LLC lifted its stake in shares of Sotera Health by 20.4% during the 3rd quarter. MetLife Investment Management LLC now owns 79,003 shares of the company’s stock worth $1,319,000 after purchasing an additional 13,399 shares during the period. Mudita Advisors LLP boosted its holdings in shares of Sotera Health by 5.2% during the third quarter. Mudita Advisors LLP now owns 406,329 shares of the company’s stock worth $6,786,000 after purchasing an additional 20,000 shares during the last quarter. Finally, FMR LLC grew its position in shares of Sotera Health by 259.9% in the third quarter. FMR LLC now owns 32,483 shares of the company’s stock valued at $542,000 after purchasing an additional 23,457 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on SHC shares. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Thursday, November 21st. Citigroup increased their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. Finally, Barclays boosted their target price on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $16.50.

Sotera Health Stock Performance

Sotera Health stock opened at $12.83 on Wednesday. The company has a market cap of $3.63 billion, a price-to-earnings ratio of 51.32 and a beta of 1.96. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The stock’s 50-day moving average is $15.10 and its 200-day moving average is $14.07.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The business had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period last year, the company posted $0.18 EPS. Equities analysts anticipate that Sotera Health will post 0.61 earnings per share for the current year.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the sale, the director now owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. This represents a 16.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 55.12% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.